UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Overview of glutamatergic neurotransmission in the nervous system

Pharmacology, biochemistry and behavior, 2012-02, Vol.100 (4), p.656-664

2012

Volltextzugriff (PDF)

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Journal of affective disorders, 2014-04, Vol.159, p.56-61

2014

Volltextzugriff (PDF)

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

Biological psychiatry (1969), 2017-05, Vol.81 (10), p.886-897

2017

Volltextzugriff (PDF)

Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression

Journal of affective disorders, 2018-05, Vol.232, p.310-315

2018

Volltextzugriff (PDF)

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine

Journal of psychopharmacology (Oxford), 2015-05, Vol.29 (5), p.596-607

2015

Volltextzugriff (PDF)

Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds

Annual review of pharmacology and toxicology, 2014-01, Vol.54 (1), p.119-139

2014

Volltextzugriff (PDF)

NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (41), p.16720-16725

2012

Volltextzugriff (PDF)

Characterizing the course of suicidal ideation response to ketamine

Journal of affective disorders, 2018-12, Vol.241, p.86-93

2018

Volltextzugriff (PDF)

Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders

CNS drugs, 2013-10, Vol.27 (10), p.777-787

2013

Volltextzugriff (PDF)

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

Journal of Neural Transmission, 2014-08, Vol.121 (8), p.907-924

2014

Volltextzugriff (PDF)

Symptomatology and Predictors of Antidepressant Efficacy in Extended Responders to a Single Ketamine Infusion

Journal of affective disorders, 2017-01, Vol.208, p.560-566

2017

Volltextzugriff (PDF)

Anhedonia as a Clinical Correlate of Suicidal Thoughts in Clinical Ketamine Trials

Journal of affective disorders, 2017-08, Vol.218, p.195-200

2017

Volltextzugriff (PDF)

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

EJNMMI research, 2018-07, Vol.8 (1), p.57-9, Article 57

2018

Volltextzugriff (PDF)

Transcranial magnetic stimulation induces heart rate decelerations independent of treatment outcome

Brain stimulation, 2023-07, Vol.16 (4), p.1044-1046

2023

Volltextzugriff (PDF)

Defining anxious depression: a review of the literature

CNS Spectrums, 2013-10, Vol.18 (5), p.252-260

2013

Volltextzugriff (PDF)

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression

Psychopharmacology, 2016-03, Vol.233 (6), p.1119-1130

2016

Volltextzugriff (PDF)

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Bipolar disorders, 2015-06, Vol.17 (4), p.438-443

2015

Volltextzugriff (PDF)

Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales

Journal of affective disorders, 2018-04, Vol.231, p.51-57

2018

Volltextzugriff (PDF)

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Current neuropharmacology, 2017-01, Vol.15 (1), p.57-70

2017

Volltextzugriff (PDF)

Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology

Chronic Stress, 2021, Vol.5, p.247054702110142-24705470211014210

2021

Volltextzugriff (PDF)

Ketamine for depression: evidence, challenges and promise

World psychiatry, 2015-10, Vol.14 (3), p.348-350

2015

Volltextzugriff (PDF)

Anticonvulsants for the Treatment of Alcohol Withdrawal Syndrome and Alcohol Use Disorders

CNS drugs, 2015-04, Vol.29 (4), p.293-311

2015

Volltextzugriff (PDF)

Clinical predictors of ketamine response in treatment-resistant major depression

The journal of clinical psychiatry, 2014-05, Vol.75 (5), p.e417

2014

Volltextzugriff (PDF)

Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder

The journal of clinical psychiatry, 2017-09, Vol.78 (8), p.1068

2017

Volltextzugriff (PDF)

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

Journal of affective disorders, 2024-02, Vol.346, p.221-222

2024

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(55)
Psychiatry
(54)
Humans
(48)
Neurosciences & Neurology
(35)
Female
(30)
Adult
(29)
Male
(28)
Middle Aged
(27)
Neurosciences
(25)
Depressive Disorder, Major - Drug Therapy
(24)
Ketamine
(23)
Clinical Neurology
(21)
Depression
(21)
Major Depressive Disorder
(19)
Mental Depression
(18)
Antidepressive Agents - Therapeutic Use
(17)
Ketamine - Therapeutic Use
(16)
Treatment Outcome
(16)
Glutamate
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Overview of glutamatergic neurotransmission in the nervous system

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine

Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds

NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia

Characterizing the course of suicidal ideation response to ketamine

Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

Symptomatology and Predictors of Antidepressant Efficacy in Extended Responders to a Single Ketamine Infusion

Anhedonia as a Clinical Correlate of Suicidal Thoughts in Clinical Ketamine Trials

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

Transcranial magnetic stimulation induces heart rate decelerations independent of treatment outcome

Defining anxious depression: a review of the literature

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology

Ketamine for depression: evidence, challenges and promise

Anticonvulsants for the Treatment of Alcohol Withdrawal Syndrome and Alcohol Use Disorders

Clinical predictors of ketamine response in treatment-resistant major depression

Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

Suchergebnisse filtern